Abstract: An illustrative volumetric capture system accesses a two-dimensional (“2D”) image captured by a capture device and depicting a first subject of a particular subject type. The volumetric capture system generates a custom three-dimensional (“3D”) model of the first subject by identifying a parameter representative of a characteristic of the first subject, applying the parameter to a parametric 3D model to generate a custom mesh, and applying a custom texture based on the 2D image to the custom mesh. The volumetric capture system also accesses a motion capture video depicting motion performed by a second subject of the particular subject type. Based on the motion capture video, the volumetric capture system animates the custom 3D model of the first subject to cause the custom 3D model to perform the motion performed by the second subject. Corresponding methods and systems are also disclosed.

Abstract: An illustrative volumetric capture system accesses a two-dimensional (“2D”) image captured by a capture device and depicting a first subject of a particular subject type. The volumetric capture system generates a custom three-dimensional (“3D”) model of the first subject by identifying a parameter representative of a characteristic of the first subject, applying the parameter to a parametric 3D model to generate a custom mesh, and applying a custom texture based on the 2D image to the custom mesh. The volumetric capture system also accesses a motion capture video depicting motion performed by a second subject of the particular subject type. Based on the motion capture video, the volumetric capture system animates the custom 3D model of the first subject to cause the custom 3D model to perform the motion performed by the second subject. Corresponding methods and systems are also disclosed.

Abstract: A new antibacterially active agent has been isolated from Streptomyces clavuligerus. This new compound which is designated clavulanic acid has the formula (I): In addition to being a broad spectrum antibiotic of medium potency, clavulanic acid and its salts and esters have the ability to enhance the effectiveness of &bgr; lactam antibiotics against many &bgr;-lactamase producing bacteria.

Abstract: A new antibacterially active agent has been isolated from Streptomyces clavuligerus. This new compound which is designated clavulanic acid has the formula (I): ##STR1## In addition to being a broad spectrum antibiotic of medium potency, clavulanic acid and its salts and esters have the ability to enhance the effectiveness of .beta.-lactam antibiotics against many .beta.-lactamase producing bacteria.